Kalbe Group News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Kalbe group. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Kalbe Group Today - Breaking & Trending Today

Kalbe wins five awards on environmental innovation

Indonesia's pharmaceutical company PT Kalbe Farma won five awards, three of them were in the platinum category, in the environmental and social . ....

Jawa Timur , Central Java , Jawa Tengah , Jawa Barat , West Java , Sherly Septiana Harjo , Kalbe Farma , Abi Nisaka , Nation Health , Energy Efficiency , Kalbe Group , Head Of Tirta Asri Association , Gumaya Hotel , Social Innovation Awards , Bekasi District , Water Efficiency , Pharma Manufacturing , Quality Sherly Septiana Harjo , Social Innovation , Local Hero , Matheus Dwi Pramono , Tirta Asri , Joint Sustainability Commitment , Sustainability Senior Manager Abi Nisaka ,

The Downfall of Insurance Industries in Indonesia - The Science Agriculture

The Downfall of Insurance Industries in Indonesia-Indonesia is the emerging economic country but faced many destructive cases in insurance. ....

Bumi Asih , Jawa Barat , Jakarta Raya , United States , Jiwasraya Syahwirman , Asuransi Jiwasraya Persero , Asuransi Jiwa Kresna , Asuransi Jiwa Mahkota , Asuransi Jiwa Bumiputera , Asuransi Jiwa Bakrie , Yanes Yaneman Matulatuwa , Asuransi Mitra Maparya , Maxima Integra Joko Hartono , Asuransi Jiwa Bersama , Rahim Hendrisman , Asuransi Jiwa Centris , Abareskrim Polri , Asuransi Kresna Mitra , Daniel Halim , Asuransi Jiwa Mahkota Abadi , Evelina Larasati Fadil , Asuransi Bumi Asih Jaya , Rezanantha Petruschka , Manfred Armin Pietruschka , Jiwasraya Hary Prasetyo , Alam Minera Heru Hidayat ,

PT Kalbe Farma Tbk (via Public) / General Atlantic to Invest US$55 Million in Kalbe Genexine Biologics

General Atlantic to Invest US$55 Million in Kalbe Genexine Biologics
General Atlantic to Invest US$55 Million in Kalbe Genexine Biologics
Capital to fuel Company s strategic growth into a leading biologics platform in the Southeast Asia region
Jakarta, Indonesia - January 27, 2021 - Kalbe Genexine Biologics ( KGBio or the Company ), a leading integrate biologics holding company focused on the in-licensing, clinical development, and manufacturing of novel biologicals and biosimilar molecules, today announced that General Atlantic, a leading global growth equity firm, will invest US$55 million in primary capital in the Company. The investment will support KGBio s ongoing clinical development and commercialization needs, asset acquisition plan, and production capacity expansion efforts. ....

New York , United States , Hong Kong , Mexico City , Distrito Federal , City Of , United Kingdom , Noord Holland , Palo Alto , South Korea , Jakarta Raya , Medika Kalbio , Innogene Kalbiotech , Ashish Saboo , Irawaty Setiady , Kalbe Genexine Biologics Kgbio , Sandeep Naik , Kalbe Farma , Genexine Inc , Kalbe Group , Genexine Biologics , General Atlantic , Southeast Asia , President Commissioner , Managing Director , Sung Young Chul ,